It is more like week after.
Is PAB presenting with Onyx or on their own?
Melbourne, Australia; 10 October, 2013: Patrys Limited (ASX: PAB), a clinical stage biotechnology
company has announced that results related to its novel anti-cancer PAT-SM6 lead clinical candidate
and data generated to date from the ongoing clinical trial in multiple myeloma has been accepted
for presentation at the 55th
ASH Annual Meeting and Exposition, run by the American Society of
Hematology in New Orleans, to be held on 7- 10 December 2013.
ann: data from final cohort of patients, page-21
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1853666 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3325244 | 5 |
View Market Depth
| Last trade - 16.12pm 16/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable